A combination HIV reporter virus system for measuring post-entry event efficiency and viral outcome in primary CD4+ T cell subsets

Journal of Virological Methods

Volumn 195, Issue , 2014, Pages 164-169

  Tilton, Carisa A ^a   Tabler, Caroline O ^a   Lucera, Mark B ^a   Marek, Samantha L ^a   Haqqani, Aiman A ^a   Tilton, John C ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fusion; HIV; LTR; Outcome; Post entry event efficiency; Reporter virus

Indexed keywords

CD27 ANTIGEN; CD45RO ANTIGEN; CHEMOKINE RECEPTOR CCR7; VIRUS PROTEIN; VPR PROTEIN;

ARTICLE; CD4+ T LYMPHOCYTE; CELL SELECTION; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE EXPRESSION; HIGH THROUGHPUT SCREENING; HOST CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; LIFE CYCLE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; REPORTER GENE; VIRAL TROPISM; VIRUS ENTRY; VIRUS ENVELOPE; VIRUS GENOME; VIRUS INFECTION; VIRUS REPLICATION;

FUSION; HIV; LTR; OUTCOME; POST-ENTRY EVENT EFFICIENCY; REPORTER VIRUS;

CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; GENE EXPRESSION; GENES, REPORTER; HIV; HUMANS; REVERSE TRANSCRIPTION; STAINING AND LABELING; VIROLOGY; VIRUS INTEGRATION; VIRUS UNCOATING;

EID: 84887257254     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2013.08.029     Document Type: Article

References (27)

1. Archin N.M., Espeseth A., Parker D., Cheema M., Hazuda D., Margolis D.M. Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid. AIDS Res. Hum. Retroviruses 2009, 25:207-212.
2. Bobadilla S., Sunseri N., Landau N.R. Efficient transduction of myeloid cells by an HIV-1-derived lentiviral vector that packages the Vpx accessory protein. Gene Ther. 2012.
3. Busschots K., De Rijck J., Christ F., Debyser Z. In search of small molecules blocking interactions between HIV proteins and intracellular cofactors. Mol. Biosyst. 2009, 5:21-31.
4. Cavrois M., De Noronha C., Greene W.C. A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. Nat. Biotechnol. 2002, 20:1151-1154.
5. Chun T.W., Fauci A.S. HIV reservoirs: pathogenesis and obstacles to viral eradication and cure. AIDS 2012, 26:1261-1268.
6. Chun T.W., Finzi D., Margolick J., Chadwick K., Schwartz D., Siliciano R.F. In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency. Nat. Med. 1995, 1:1284-1290.
7. Doitsh G., Cavrois M., Lassen K.G., Zepeda O., Yang Z., Santiago M.L., Hebbeler A.M., Greene W.C. Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue. Cell 2010, 143:789-801.
8. Durand S., Nguyen X.-N., Turpin J., Cordeil S., Nazaret N., Croze S., Mahieux R., Lachuer J., Legras-Lachuer C., Cimarelli A. Tailored HIV-1 vectors for the genetic modification of primary human dendritic cells and monocytes. J. Virol. 2012.
9. Finzi D., Hermankova M., Pierson T., Carruth L.M., Buck C., Chaisson R.E., Quinn T.C., Chadwick K., Margolick J., Brookmeyer R., Gallant J., Markowitz M., Ho D.D., Richman D.D., Siliciano R.F. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997, 278:1295-1300.
10. Heinzinger N.K., Bukinsky M.I., Haggerty S.A., Ragland A.M., Kewalramani V., Lee M.A., Gendelman H.E., Ratner L., Stevenson M., Emerman M. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. PNAS 1994, 91:7311-7315.
11. Hrecka K., Hao C., Gierszewska M., Swanson S.K., Kesik-Brodacka M., Srivastava S., Florens L., Washburn M.P., Skowronski J. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 2011, 474:658-661.
12. Jäger S., Cimermancic P., Gulbahce N., Johnson J.R., McGovern K.E., Clarke S.C., Shales M., Mercenne G., Pache L., Li K., Hernandez H., Jang G.M., Roth S.L., Akiva E., Marlett J., Stephens M., D'Orso I., Fernandes J., Fahey M., Mahon C., O'Donoghue A.J., Todorovic A., Morris J.H., Maltby D.A., Alber T., Cagney G., Bushman F.D., Young J.A., Chanda S.K., Sundquist W.I., Kortemme T., Hernandez R.D., Craik C.S., Burlingame A., Sali A., Frankel A.D., Krogan N.J. Global landscape of HIV-human protein complexes. Nature 2012, 481:365-370.
13. Karn J. The molecular biology of HIV latency: breaking and restoring the Tat-dependent transcriptional circuit. Curr. Opin. HIV AIDS 2011, 6:4-11.
14. Keele B.F., Giorgi E.E., Salazar-Gonzalez J.F., Decker J.M., Pham K.T., Salazar M.G., Sun C., Grayson T., Wang S., Li H., Wei X., Jiang C., Kirchherr J.L., Gao F., Anderson J.A., Ping L.-H., Swanstrom R., Tomaras G.D., Blattner W.A., Goepfert P.A., Kilby J.M., Saag M.S., Delwart E.L., Busch M.P., Cohen M.S., Montefiori D.C., Haynes B.F., Gaschen B., Athreya G.S., Lee H.Y., Wood N., Seoighe C., Perelson A.S., Bhattacharya T., Korber B.T., Hahn B.H., Shaw G.M. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. PNAS 2008, 105:7552-7557.
15. Kutner R.H., Zhang X.-Y., Reiser J. Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat. Protoc. 2009, 4:495-505.
16. Laguette N., Sobhian B., Casartelli N., Ringeard M., Chable-Bessia C., Ségéral E., Yatim A., Emiliani S., Schwartz O., Benkirane M. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 2011, 474:654-657.
17. Maertens G., Cherepanov P., Pluymers W., Busschots K., De Clercq E., Debyser Z., Engelborghs Y. LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells. J. Biol. Chem. 2003, 278:33528-33539.
18. O'Doherty U., Swiggard W.J., Malim M.H. Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J. Virol. 2000, 74:10074-10080.
19. Piatak M., Saag M.S., Yang L.C., Clark S.J., Kappes J.C., Luk K.C., Hahn B.H., Shaw G.M., Lifson J.D. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993, 259:1749-1754.
20. Sastry L., Johnson T., Hobson M.J., Smucker B., Cornetta K. Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods. Gene Ther. 2002, 9:1155-1162.
21. Siliciano R.F. What do we need to do to cure HIV infection. Top. HIV Med. 2010, 18:104-108. (a publication of the International AIDS Society, USA).
22. Wilen C.B., Parrish N.F., Pfaff J.M., Decker J.M., Henning E.A., Haim H., Petersen J.E., Wojcechowskyj J.A., Sodroski J., Haynes B.F., Montefiori D.C., Tilton J.C., Shaw G.M., Hahn B.H., Doms R.W. Phenotypic and immunologic comparison of clade B transmitted/founder and chronic HIV-1 envelope glycoproteins. J. Virol. 2011, 85:8514-8527.
23. Wilen C.B., Tilton J.C., Doms R.W. HIV: cell binding and entry. Cold Spring Harb. Perspect. Med. 2012, 2.
24. Wolf M.C., Wang Y., Freiberg A.N., Aguilar H.C., Holbrook M.R., Lee B. A catalytically and genetically optimized beta-lactamase-matrix based assay for sensitive, specific, and higher throughput analysis of native henipavirus entry characteristics. Virol. J. 2009, 6:119.
25. Zack J.A., Arrigo S.J., Weitsman S.R., Go A.S., Haislip A., Chen I.S. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 1990, 61:213-222.
26. Zhang H., Zhou Y., Alcock C., Kiefer T., Monie D., Siliciano J., Li Q., Pham P., Cofrancesco J., Persaud D., Siliciano R.F. Novel single-cell-level phenotypic assay for residual drug susceptibility and reduced replication capacity of drug-resistant human immunodeficiency virus type 1. J. Virol. 2004, 78:1718-1729.
27. Zhou Y., Zhang H., Siliciano J.D., Siliciano R.F. Kinetics of human immunodeficiency virus type 1 decay following entry into resting CD4+ T cells. J. Virol. 2005, 79:2199-2210.